tert-butyl 2,2-dimethyl-4-oxo-1-piperidinecarboxylate, 95.0%, 10g

5-methylbenzo[b]thiophen-3(2H)-one, 95.0%, 500mg

(4-(2-(tert-Butoxy)-2-oxoethyl)phenyl)boronic acid, 95+%, 1g

2-[4-(2,2-Dimethylpropanoyl)piperazin-1-yl]ethanol hydrochloride, 95.0%, 500mg

3-[(4-methoxyphenyl)thio]propanoic acid, 95.0%, 1g

4-(4-Propylpiperazin-1-yl)benzoic acid, 97%, 250mg

6-Bromophthalazine, 95.0%, 100mg

1-Boc-4-(Methoxy-methyl-carbamoyl)-piperidine, 98.0%, 25g

(S)-Ethyl 3-(4-bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoate, 95%, 5g

2,3-Dimethylbutane>98.0%(GC)25mL

(4-(Cyclohexyl(methyl)carbamoyl)phenyl)boronic acid, 95.0%, 5g

Methyl 5-(4,4,5-trimethyl-[1,3,2]dioxaborolan-2-yl)thiophene-2-carboxylate, 95.0%, 5g

Ethylene Glycol, min 99%, for synthesis, 25 l, plastic packaging.